Labeler
Zydus Pharmaceuticals USA Inc. NDC Codes
Zydus Pharmaceuticals USA Inc. lists 626 finished drug products in the FDA NDC Directory under NDC labeler codes 68382, 70710.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Isotretinoin, Riociguat, brivaracetam, dasatinib, tofacitinib, Eltrombopag, Beizray, Carbidopa and Levodopa, Jaythari, Deflazacort, gadobutrol, Verapamil hydrochloride, Diazepam, gabapentin, oxcarbazepine
- Active ingredients
- Deflazacort, Isotretinoin, Riociguat, Brivaracetam, Dasatinib, Tofacitinib citrate, Eltrombopag olamine, Carbidopa, Levodopa, Gadobutrol, Verapamil hydrochloride, Diazepam
- NDC labeler codes
- 68382, 70710
- Strengths (from the 100 most recently listed products)
- Gadobutrol 604.72 mg/mL; Docetaxel anhydrous 20 mg/mL; Deflazacort 22.75 mg/mL; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Deflazacort 36 mg/1; Deflazacort 6 mg/1; Riociguat .5 mg/1; Riociguat 1 mg/1; Riociguat 1.5 mg/1; Riociguat 2 mg/1; Riociguat 2.5 mg/1; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Ranibizumab .3 mg/.05mL; Ranibizumab .5 mg/.05mL; Tofacitinib citrate 10 mg/1; Fluorescein sodium 100 mg/mL
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Solution, Capsule, Injection, Capsule, Extended release, Kit, Gel, Tablet, Extended release, Tablet, Film coated, Extended release, Suspension, Liquid, Tablet, For suspension, Powder, For solution
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Rectal, Intravitreal
- Drug classes (FDA established)
- Corticosteroid, Serotonin Reuptake Inhibitor, Retinoid, Soluble Guanylate Cyclase Stimulator, Kinase Inhibitor, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Aromatic Amino Acid, Anti-epileptic Agent, Gadolinium-based Contrast Agent, Calcium Channel Blocker, Benzodiazepine, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Tetracycline-class Drug, Vascular Endothelial Growth Factor Inhibitor, Diagnostic Dye, Nitrogen Binding Agent, Sodium-Glucose Cotransporter 2 Inhibitor, Endothelin Receptor Antagonist, Microtubule Inhibitor, CCR5 Co-receptor Antagonist, Calcitonin, Oxidation-Reduction Agent, Phosphate Binder, Xanthine Oxidase Inhibitor, Arteriolar Vasodilator, Enzyme Stabilizer, Glucosylceramide Synthase Inhibitor
- HCPCS / J-code
- J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 166 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Sitagliptin | Sitagliptin 100 mg/1 | TabletOral | 70710-1901 | 70710-1901-0370710-1901-09 | — |
| Zituviositagliptin | Sitagliptin 25 mg/1 | TabletOral | 70710-1240 | 70710-1240-0370710-1240-09 | — |
| Zituviositagliptin | Sitagliptin 50 mg/1 | TabletOral | 70710-1241 | 70710-1241-0370710-1241-09 | — |
| Zituviositagliptin | Sitagliptin 100 mg/1 | TabletOral | 70710-1242 | 70710-1242-0370710-1242-09 | — |
| norelgestromin and ethinyl estradiol | Norelgestromin 150 ug/mg; Ethinyl estradiol 35 ug/mg | PatchTransdermal | 70710-1190 | 70710-1190-03 | — |
| Topiramate | Topiramate 200 mg/1 | Capsule, Extended releaseOral | 68382-358 | 68382-0358-0168382-0358-0568382-0358-06+1 more | — |
| estradiol | Estradiol .014 mg/d | PatchTransdermal | 68382-323 | 68382-0323-04 | — |
| estradiol | Estradiol .025 mg/d | PatchTransdermal | 68382-324 | 68382-0324-04 | — |
| estradiol | Estradiol .0375 mg/d | PatchTransdermal | 68382-325 | 68382-0325-04 | — |
| estradiol | Estradiol .05 mg/d | PatchTransdermal | 68382-326 | 68382-0326-04 | — |
| estradiol | Estradiol .06 mg/d | PatchTransdermal | 68382-327 | 68382-0327-04 | — |
| estradiol | Estradiol .075 mg/d | PatchTransdermal | 68382-328 | 68382-0328-04 | — |
| estradiol | Estradiol .1 mg/d | PatchTransdermal | 68382-329 | 68382-0329-04 | — |
| pitavastatin calcium | Pitavastatin calcium 2 mg/1 | TabletOral | 68382-482 | 68382-0482-16 | — |
| pitavastatin calcium | Pitavastatin calcium 4 mg/1 | TabletOral | 68382-483 | 68382-0483-16 | — |
| pitavastatin calcium | Pitavastatin calcium 1 mg/1 | TabletOral | 68382-481 | 68382-0481-16 | — |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | 70710-1937 | 70710-1937-07 | — |
| Sodium phenylacetate and Sodium benzoate | Sodium phenylacetate 100 mg/mL; Sodium benzoate 100 mg/mL | Injection, Solution, ConcentrateIntravenous | 70710-1926 | 70710-1926-01 | — |
| Isotretinoin | Isotretinoin 20 mg/1 | CapsuleOral | 70710-1023 | 70710-1023-0470710-1023-08 | — |
| Isotretinoin | Isotretinoin 30 mg/1 | CapsuleOral | 70710-1024 | 70710-1024-08 | — |
| Isotretinoin | Isotretinoin 40 mg/1 | CapsuleOral | 70710-1025 | 70710-1025-0470710-1025-08 | — |
| Isotretinoin | Isotretinoin 10 mg/1 | CapsuleOral | 70710-1022 | 70710-1022-0470710-1022-08 | — |
| balsalazide disodium | Balsalazide disodium 750 mg/1 | CapsuleOral | 70710-1626 | 70710-1626-01 | — |
| icosapent ethyl | Icosapent ethyl .5 g/1 | CapsuleOral | 70710-1738 | 70710-1738-04 | — |
| acetaZOLAMIDE | Acetazolamide 125 mg/1 | TabletOral | 70710-1238 | 70710-1238-01 | — |
| acetaZOLAMIDE | Acetazolamide 250 mg/1 | TabletOral | 70710-1239 | 70710-1239-01 | — |
| icosapent ethyl | Icosapent ethyl 1 g/1 | CapsuleOral | 70710-1592 | 70710-1592-07 | — |
| Indomethacin | Indomethacin 50 mg/1 | SuppositoryRectal | 70710-1852 | 70710-1852-07 | — |
| Plerixafor | Plerixafor 24 mg/1.2mL | InjectionSubcutaneous | 70710-1208 | 70710-1208-01 | — |
| Erythromycin | Erythromycin 250 mg/1 | Tablet, Film coatedOral | 70710-1047 | 70710-1047-0170710-1047-0370710-1047-05 | — |
| Erythromycin | Erythromycin 500 mg/1 | Tablet, Film coatedOral | 70710-1048 | 70710-1048-0170710-1048-0370710-1048-05 | — |
| Esomeprazole Magnesium | Esomeprazole magnesium dihydrate 20 mg/1 | Granule, Delayed releaseOral | 68382-848 | 68382-0848-94 | — |
| Esomeprazole Magnesium | Esomeprazole magnesium dihydrate 40 mg/1 | Granule, Delayed releaseOral | 68382-849 | 68382-0849-94 | — |
| Varenicline | Varenicline tartrate .5 mg/1 | Tablet, Film coatedOral | 70710-1613 | 70710-1613-06 | — |
| Varenicline | Varenicline tartrate 1 mg/1 | Tablet, Film coatedOral | 70710-1614 | 70710-1614-06 | — |
| Venlafaxine Hydrochloride | Venlafaxine hydrochloride 37.5 mg/1 | Capsule, Extended releaseOral | 70710-1698 | 70710-1698-0070710-1698-0370710-1698-04+2 more | — |
| Venlafaxine Hydrochloride | Venlafaxine hydrochloride 75 mg/1 | Capsule, Extended releaseOral | 70710-1699 | 70710-1699-0070710-1699-0370710-1699-04+2 more | — |
| Venlafaxine Hydrochloride | Venlafaxine hydrochloride 150 mg/1 | Capsule, Extended releaseOral | 70710-1700 | 70710-1700-0070710-1700-0370710-1700-04+2 more | — |
| Roflumilast | Roflumilast 250 ug/1 | TabletOral | 68382-624 | 68382-0624-3168382-0624-83 | — |
| Estradiol | Estradiol .025 mg/d | Patch, Extended releaseTransdermal | 70710-1191 | 70710-1191-08 | — |
| Estradiol | Estradiol .0375 mg/d | Patch, Extended releaseTransdermal | 70710-1192 | 70710-1192-08 | — |
| Estradiol | Estradiol .05 mg/d | Patch, Extended releaseTransdermal | 70710-1193 | 70710-1193-08 | — |
| Estradiol | Estradiol .075 mg/d | Patch, Extended releaseTransdermal | 70710-1194 | 70710-1194-08 | — |
| Estradiol | Estradiol .1 mg/d | Patch, Extended releaseTransdermal | 70710-1195 | 70710-1195-08 | — |
| Micafungin | Micafungin sodium 10 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70710-1724 | 70710-1724-0170710-1724-06 | — |
| Micafungin | Micafungin sodium 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70710-1725 | 70710-1725-0170710-1725-06 | — |
| Lubiprostone | Lubiprostone 8 ug/1 | CapsuleOral | 70710-1641 | 70710-1641-0170710-1641-06 | — |
| Lubiprostone | Lubiprostone 24 ug/1 | CapsuleOral | 70710-1642 | 70710-1642-0170710-1642-06 | — |
| Buspirone hydrochloride | Buspirone hydrochloride 7.5 mg/1 | TabletOral | 68382-623 | 68382-0623-0168382-0623-0568382-0623-10+1 more | — |
| Lenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 70710-1030 | 70710-1030-0170710-1030-07 | — |
Zydus Pharmaceuticals USA Inc.: common questions
- What is Zydus Pharmaceuticals USA Inc.'s NDC labeler code?
- 68382, 70710. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.